PanTher Therapeutics has been selected for the prestigious MedTech Innovator 2023 Program in the mid-stage company cohort. Among a competitive pool of ~1,150 company applicants, nearly 200 advanced to the in-person pitch and partnering events on the MedTech Innovator Road Tour. Over 400 industry experts completed four months of diligence, selecting PanTher to be among the 61 startups selected for this cohort.
PanTher Therapeutics